Organ-sparing Intensity-modulated Radiotherapy for Anal Cancer using the ACTII Schedule: A Comparison of Conventional and Intensity-modulated Radiotherapy Plans

Clinical Oncology

Volumn 25, Issue 3, 2013, Pages 155-161

  Brooks, C J ^a   Lee, Y K ^a   Aitken, K ^a   Hansen, V N ^a   Tait, D M ^a   Hawkins, M A ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

ACTII; Anal cancer; IMRT

Indexed keywords

ANUS CANCER; ARTICLE; BLADDER; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; FEMUR HEAD; GENITAL SYSTEM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SMALL INTESTINE;

ANUS NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84873099389     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.08.008     Document Type: Article

References (20)

1. James R., Wan S., Glynne-Jones R., et al. A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II) (abstract LBA4009). J Clin Oncol 2009, 27:18S.
2. Menkarios C., Azria D., Laliberte B., et al. Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal carcinoma: a comparison of conventional and IMRT plans. Radiat Oncol 2007, 2:41.
3. Konski A., Garcia M., John M., et al. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys 2008, 72:114-118.
4. Roohipour R., Patil S., Goodman K.A., et al. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2008, 51:147-153.
5. Ajani J.A., Winter K.A., Gunderson L.L., et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008, 299:1914-1921.
6. Milano M.T., Jani A.B., Farrey K.J., Rash C., Heimann R., Chmura S.J. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2005, 63:354-361.
7. Salama J.K., Mell L.K., Schomas D.A., et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 2007, 25:4581-4586.
8. Kachnic L., Winter K., Myerson R., et al. RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2009, 75:S1.
9. Elective Clinical Target Volumes in Anorectal Cancer: An RTOG Consensus Panel Contouring Atlas. Available at: [accessed 15.03.11]. http://www.rtog.org/LinkClick.aspx%3Ffileticket%3DDgflROvKQ6w%253d%26tabid%3D231.
10. Shaw E., Kline R., Gillin M., et al. Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. J Radiat Oncol Biol Phys 1993, 27:1231-1239.
11. Nguyen N.P., Antoine J.E., Dutta S., Karlsson U., Sallah S. Current concepts in radiation enteritis and implications for future clinical trials. Cancer 2002, 95:1151-1163.
12. Devisetty K., Mell L.K., Salama J.K., et al. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol 2009, 93:298-301.
13. Meyer J., Czito B., Yin F., Willett C. Advanced radiation therapy technologies in the treatment of rectal and anal cancer: intensity-modulated photon therapy and proton therapy. Clin Colorectal Cancer 2007, 6:348-356.
14. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
15. Dzik-Jurasz A., Brooker S., Husband J., Tait D. What is the prevalence of symptomatic or asymptomatic femoral head osteonecrosis in patients previously treated with chemoradiation? A magnetic resonance study of anal cancer patients. Clin Oncol 2001, 13:130-134.
16. Cancer Research UK. [accessed 13.12.11]. http://info.cancerresearchuk.org/cancerstats/types/bowel/incidence/#age/.
17. Kachnic L., Tsai H., Coen J., et al. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys 2012, 82:153-158.
18. Lin A., Ben-Josef E. Intensity-modulated radiation therapy for the treatment of anal cancer. Clin Colorectal Cancer 2007, 6:716-719.
19. Brooks C., Lee Y., Aitken K., et al. Organ sparing IMRT for anal cancer using ACTII schedule: a comparison of conventional and IMRT plans. Clin Oncol 2011, 23:S31.
20. Clivio A., Fogliata A., Franzetti-Pellanda A., et al. Volumetric-modulated arc radiotherapy for carcinomas of the anal cancer: a treatment planning comparison with fixed field IMRT. Radiother Oncol 2009, 92:118-124.